Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Apr;77(4):1382–1386. doi: 10.1172/JCI112444

Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.

T Sasaki, T Muryoi, O Takai, E Tamate, Y Ono, Y Koide, N Ishida, K Yoshinaga
PMCID: PMC424502  PMID: 2937806

Abstract

A new strategy was shown for the manipulation of autoantibody production in humans. Antiidiotypic antibody to human anti-DNA autoantibody was conjugated with neocarzinostatin (NCS), a cytotoxic agent, by using N-succimidyl 3-(2-pyridyldithio) propionate as a coupling agent. Human B cell clones, which produce anti-DNA autoantibodies, were killed by in vitro treatment with antiidiotype (Id)-NCS conjugates, while clones expressing an Id with irrelevant specificity were unaffected. These results indicate that treatment with anti-Id-NCS conjugates can act as a potent and specific means of generating immunosuppression of autoantibody production. This approach will have a significant advantage in aborting clones that are not effectively suppressed for the autoantibodies by anti-Id antibodies alone, and will result in a potential therapeutic treatment for systemic lupus erythematosus.

Full text

PDF
1385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Wall H., Lindsley H. B., Halsey J. F., Suzuki T. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest. 1981 May;67(5):1297–1304. doi: 10.1172/JCI110158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bona C., Paul W. E. Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med. 1979 Mar 1;149(3):592–600. doi: 10.1084/jem.149.3.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borel Y., Lewis R. M., Stollar B. D. Prevention of murine lupus nephritis by carrier-dependent induction of immunologic tolerance to denatured DNA. Science. 1973 Oct 5;182(4107):76–78. doi: 10.1126/science.182.4107.76. [DOI] [PubMed] [Google Scholar]
  4. Cohen S. A., Hughes G. R., Noel G. L., Christian C. L. Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1971 Apr;8(4):551–561. [PMC free article] [PubMed] [Google Scholar]
  5. De Weger R. A., Dullens H. F., Den Otter W. Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexes. Immunol Rev. 1982;62:28–45. doi: 10.1111/j.1600-065x.1982.tb00388.x. [DOI] [PubMed] [Google Scholar]
  6. Dwyer D. S., Bradley R. J., Urquhart C. K., Kearney J. F. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature. 1983 Feb 17;301(5901):611–614. doi: 10.1038/301611a0. [DOI] [PubMed] [Google Scholar]
  7. Ebling F., Hahn B. H. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum. 1980 Apr;23(4):392–403. doi: 10.1002/art.1780230402. [DOI] [PubMed] [Google Scholar]
  8. Eichmann K., Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. 1975 Oct;5(10):661–666. doi: 10.1002/eji.1830051002. [DOI] [PubMed] [Google Scholar]
  9. Geha R. S. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol. 1982 Jul;129(1):139–144. [PubMed] [Google Scholar]
  10. Hahn B. H., Ebling F. M. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol. 1984 Jan;132(1):187–190. [PubMed] [Google Scholar]
  11. Isenberg D. A., Collins C. Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest. 1985 Jul;76(1):287–294. doi: 10.1172/JCI111959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Isenberg D. A., Shoenfeld Y., Madaio M. P., Rauch J., Reichlin M., Stollar B. D., Schwartz R. S. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet. 1984 Aug 25;2(8400):417–422. doi: 10.1016/s0140-6736(84)92904-0. [DOI] [PubMed] [Google Scholar]
  13. Jansen F. K., Blythman H. E., Carrière D., Casellas P., Gros O., Gros P., Laurent J. C., Paolucci F., Pau B., Poncelet P. Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity. Immunol Rev. 1982;62:185–216. doi: 10.1111/j.1600-065x.1982.tb00394.x. [DOI] [PubMed] [Google Scholar]
  14. Jung G., Köhnlein W., Lüders G. Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate. Biochem Biophys Res Commun. 1981 Jul 30;101(2):599–606. doi: 10.1016/0006-291x(81)91301-2. [DOI] [PubMed] [Google Scholar]
  15. Koffler D., Carr R., Agnello V., Thoburn R., Kunkel H. G. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med. 1971 Jul 1;134(1):294–312. doi: 10.1084/jem.134.1.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Koffler D., Schur P. H., Kunkel H. G. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967 Oct 1;126(4):607–624. doi: 10.1084/jem.126.4.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Koopman W. J., Schrohenloher R. E., Barton J. C., Greenleaf E. C. Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements. J Clin Invest. 1983 Oct;72(4):1410–1419. doi: 10.1172/JCI111097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  19. Maeda H., Matsumoto M. Cytotoxic effect of neocarzinostatin on human lymphoid cells. Tohoku J Exp Med. 1979 Aug;128(4):313–323. [PubMed] [Google Scholar]
  20. Marion T. N., Lawton A. R., 3rd, Kearney J. F., Briles D. E. Anti-DNA autoantibodies in (NZB X NZW)F1 mice are clonally heterogeneous, but the majority share a common idiotype. J Immunol. 1982 Feb;128(2):668–674. [PubMed] [Google Scholar]
  21. Rauch J., Murphy E., Roths J. B., Stollar B. D., Schwartz R. S. A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice. J Immunol. 1982 Jul;129(1):236–241. [PubMed] [Google Scholar]
  22. Sasaki T., Endo F., Mikami M., Sekiguchi Y., Tada K., Ono Y., Ishida N., Yoshinaga K. Establishment of human monoclonal anti-DNA antibody producing cell lines. J Immunol Methods. 1984 Aug 3;72(1):157–165. doi: 10.1016/0022-1759(84)90443-5. [DOI] [PubMed] [Google Scholar]
  23. Sasaki T., Kadono T., Endo F., Ishida S., Yoshinaga K. Induction of immunological tolerance to single-stranded and double-stranded DNA. Scand J Immunol. 1982 Sep;16(3):191–200. doi: 10.1111/j.1365-3083.1982.tb00714.x. [DOI] [PubMed] [Google Scholar]
  24. Sasaki T., Muryoi T., Sekiguchi Y., Tamate E., Yoshinaga K., Kitagawa Y. Monoclonal human anti-DNA antibodies from EB virus-transformed lymphocytes of systemic lupus erythematosus (SLE) patients. J Clin Immunol. 1985 Jul;5(4):246–253. doi: 10.1007/BF00929459. [DOI] [PubMed] [Google Scholar]
  25. Shoenfeld Y., Isenberg D. A., Rauch J., Madaio M. P., Stollar B. D., Schwartz R. S. Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med. 1983 Sep 1;158(3):718–730. doi: 10.1084/jem.158.3.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shoenfeld Y., Rauch J., Massicotte H., Datta S. K., André-Schwartz J., Stollar B. D., Schwartz R. S. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med. 1983 Feb 24;308(8):414–420. doi: 10.1056/NEJM198302243080802. [DOI] [PubMed] [Google Scholar]
  27. Tan E. M., Schur P. H., Carr R. I., Kunkel H. G. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966 Nov;45(11):1732–1740. doi: 10.1172/JCI105479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Teitelbaum D., Rauch J., Stollar B. D., Schwartz R. S. In vivo effects of antibodies against a high frequency idiotype of anti-DNA antibodies in MRL mice. J Immunol. 1984 Mar;132(3):1282–1285. [PubMed] [Google Scholar]
  29. Tojo T., Friou G. J. Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei. Science. 1968 Aug 30;161(3844):904–906. doi: 10.1126/science.161.3844.904. [DOI] [PubMed] [Google Scholar]
  30. Vitetta E. S., Krolick K. A., Uhr J. W. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins. Immunol Rev. 1982;62:159–183. doi: 10.1111/j.1600-065x.1982.tb00393.x. [DOI] [PubMed] [Google Scholar]
  31. Youle R. J., Neville D. M., Jr Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5483–5486. doi: 10.1073/pnas.77.9.5483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zanetti M., Rogers J., Katz D. H. Induction of autoantibodies to thyroglobulin by anti-idiotypic antibodies. J Immunol. 1984 Jul;133(1):240–243. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES